EVALUATION THE EXPRESSION OF THREE GENES TO EPITHELIAL OVARIAN CANCER RISK IN CHINESE POPULATION
- PMID: 28852723
- PMCID: PMC5566156
- DOI: 10.21010/ajtcam.v13i4.12
EVALUATION THE EXPRESSION OF THREE GENES TO EPITHELIAL OVARIAN CANCER RISK IN CHINESE POPULATION
Abstract
Background: Ovarian cancer is associated with poor survival, because patients are diagnosed at an advanced stage of the disease, and in addition, tumors develop chemoresistance, which carries a poor prognosis for the patient.
Material and methods: We hypothesize that high expression of SDF-1, survivin and smac is associated with ovarian cancers development and could be used as a biomarker to identify this disease. The expressions of SDF-1, survivin and smac in normal ovarian (NO) tissue, benign tumor (BT) tissue and epithelial ovarian cancer (EOC) tissue were immunohistochemically analysed.
Results: Positive expressions of SDF-1, survivin and smac were significantly higher in EOC tissue than those in NO and BT tissues. SDF-1 expressions were significantly more weaker in advanced ovarian carcinomas (FIGO stage III-IV), and in high-grade carcinomas. There was a positive correlation between EOC patients with lymph node metastasis and with ascites and SDF-1 positivity (P < 0.05). Survivin expressions were significantly more stronger in advanced ovarian carcinomas (FIGO stage III-IV), and in high-grade carcinomas. There was a positive correlation between EOC patients with lymph node metastasis and with ascites and surviving positivity (P < 0.05). Smac expressions were significantly more stronger in advanced ovarian carcinomas (FIGO stage III-IV), and in high-grade carcinomas. There was a positive correlation between EOC patients with lymph node metastasis and with ascites and smac positivity (P < 0.05).
Conclusion: These results indicate that SDF-1, surviving and smac are closely associated with EOC metastasis.
Keywords: Expression; Gene; Ovarian cancers; SDF-1.
Similar articles
-
Prognostic importance of survivin, Ki-67, and topoisomerase IIα in ovarian carcinoma.Arch Gynecol Obstet. 2014 Feb;289(2):393-8. doi: 10.1007/s00404-013-3000-z. Epub 2013 Aug 22. Arch Gynecol Obstet. 2014. PMID: 23974278
-
SDF-1alpha/CXCL12 and dendritic cells in ovarian cancer microenvironment.Ginekol Pol. 2011 Jun;82(6):421-5. Ginekol Pol. 2011. PMID: 21853930
-
Nuclear survivin is associated with malignant potential in epithelial ovarian carcinoma.Appl Immunohistochem Mol Morphol. 2011 Mar;19(2):126-32. doi: 10.1097/PAI.0b013e3181e30dcd. Appl Immunohistochem Mol Morphol. 2011. PMID: 20724919
-
The role of tumour-associated MUC1 in epithelial ovarian cancer metastasis and progression.Cancer Metastasis Rev. 2013 Dec;32(3-4):535-51. doi: 10.1007/s10555-013-9423-y. Cancer Metastasis Rev. 2013. PMID: 23609751 Review.
-
Current and future role of circulating tumor cells in patients with epithelial ovarian cancer.Eur J Surg Oncol. 2016 Dec;42(12):1772-1779. doi: 10.1016/j.ejso.2016.05.010. Epub 2016 May 25. Eur J Surg Oncol. 2016. PMID: 27265041 Review.
Cited by
-
Prognostic Significance of Survivin Expression in Patients with Ovarian Carcinoma: A Meta-Analysis.J Clin Med. 2021 Feb 21;10(4):879. doi: 10.3390/jcm10040879. J Clin Med. 2021. PMID: 33669912 Free PMC article. Review.
-
The mitochondrial landscape of ovarian cancer: emerging insights.Carcinogenesis. 2021 May 28;42(5):663-671. doi: 10.1093/carcin/bgab033. Carcinogenesis. 2021. PMID: 33928357 Free PMC article. Review.
References
-
- Ambrosini G, Adida C, Altieri D.C. A novel antiapoptosis gene, survivin, expressed in cancer and lymphoma, Nat. Med. 1997;3:917–921. - PubMed
-
- Antonacopoulou A.G, Floratou K, Bravou V, Kottorou A. Dimitrakopoulos F.I, Marousi S, Stavropoulos M, Koutras A.K, Scopa C.D, Kalofonos H.P. The survivin -31 snp in human colorectal cancer correlates with survivin splice variant expression and improved overall survival. Anal. Cell Pathol. (Amsterdam) 2010;33:177–189. - PMC - PubMed
-
- Arai J, Yasukawa M, Yakushijin Y, Miyazaki T, Fujita S. Stromal cells in lymph nodes attract B-lymphoma cells via production of stromal cell-derived factor-1, Eur. J. Haematol. 2000;64:323–332. - PubMed
-
- de Oliveira K.B, Guembarovski R.L, Oda J.M, Mantovani M.S, Carrera C.M, Reiche E.M, Voltarelli J.C, da Silva do Amaral Herrera A.C, Watanabe M.A. CXCL12 rs1801157 polymorphism and expression in peripheral blood from breast cancer patients. Cytokine. 2011;55:260. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical